arrow left
arrow right
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
  • Cresco Labs New York, Llc, a New York limited liability company, Cresco Labs Llc, An Illinois Limited Liability Company v. Fiorello Pharmaceuticals, Inc., a New York corporation, Eric Sirota, Susan Yoss, John Does 1 - 10 Commercial Division document preview
						
                                

Preview

SUPREME COURT OF THE STATE OF NEW YORK COUNTY OF NEW YORK -------------- =-------------------------------x : Index No. 652343/2018 : CRESCO LABS NEW YORK, LLC, a New : York limited liability company, : Hon. Charles E. Ramos : Plaintiff : v. : FIORELLO PHARMACEUTICALS, INC., a : New York corporation, ERIC SIROTA, an : individual, SUSAN YOSS, an individual, and : JOHN DOES 1-10, : Defendants. -------------- ----------x : STIPULATION Plaintiff Cresco Labs New York, LLC ("Plaintiff") and Defeñdâñts Fiorello Pharmaceuticals, Inc., Eric Sirota, and Susan Yoss (collectively, "Defendants"), by and through their respective counsel, hereby stipulate and agree to a schedule for how to proceed in thiscase. In support hereof, the Parties state as follows: WHEREAS, pursuant to stipulation on September 25, 2018, the parties agreed to an Defendants' adjournment of all proceedings in thisaction, including the briefing on pending motion to dismiss, so that they could engage in negotiations to determine whether itis possible to resolve this matter without further litigation; WHEREAS, pursuant to stipulation on September 25, 2018, the Parties are required to propose a schedule on how to proceed by November 9, 2018; WHEREAS, pursuant to an email from the Court on October 2, 2018, the return date on Defeñdants' motion to dismiss isNovember 19, 2018; WHEREAS, the Parties have agreed that Plaintiff will file an amended complaint by November 20, 2018; WHEREAS, counsel for Defendants will promptly thereafter inform counsel for Plaintiff ifthey intend to filean Answer or motion to dismiss, and the Parties will thereafter propose a schedule for this Court's consideration; Defendants' WHEREAS, the Parties have agreed that now-pending motion to dismiss shall be returnable on December 7, 2018; NOW THEREFORE, the Parties hereby stipulate and agree that (i)Plaintiff's amended complaiñt shall be due November 20, 2018; (ii)the parties will promptly thereafter propose a schedule for Defendant to file an Answer to the Amended Complaint or a motion to dismiss; (iii) Defendants' now-pending motion to dismiss shall be returnable on December 7, 2018; and (iv) for the purposes of this Stipulation, electronic or facsimile signatures shall have the same force and effect as originals and this stipulation may be executed in one or more counterparts. IT IS SO STIPULATED. JENNE BLOCK L Dated: By: Stephen L. Ascher Jason P. Hipp 919 Third Avenue New York, New York 10022 212-891-1670 sascher@jenner.com jhipp@jenner.com Counsel for Plaintiff Cresco Labs New York, LLC 2 IZOWE D A L Dated: By: Ronald D. Lefton Rachel Izower-Fadde 85 Broad Street, Floor 18 New York, New York 10004 Tel: 646.688.3232 Fax: 646.304.7071 Counselfor Defendants Fiorello Pharmaceuticals, Inc.,Eric Sirota, and Susan Yoss IT IS SO ORDERED. Dated: HONORABLE CHARLES E. RAMOS , 3